SCHEMBL699560

SCHEMBL699560

FC1(Br)[CH]C=CC=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19742932 0.67
SCHEMBL8694480 0.67
SCHEMBL7703514 0.65
SCHEMBL3241098 0.63
SCHEMBL1009203 0.62
SCHEMBL6696867 0.62
SCHEMBL2078830 0.62
SCHEMBL21247921 0.62
SCHEMBL18705923 0.62
SCHEMBL2470905 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 370 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110357806-A It is used in particular for the organic molecule of photoelectric device 辛诺拉有限公司 2019-10-22 CN claimed
CN-110279684-A For treating the purposes of 2 agonist of formyl peptide receptor of ocular inflammatory disease 阿勒根公司 2019-09-27 CN claimed
CN-110121499-A (aza) indole-, benzothiophene-and benzofuran-3-sulfonamides 优时比制药有限公司 2019-08-13 CN claimed
CN-110092788-A Substituted [1,2,4] triazol [1,5-a] pyrimidin-7-yl compound as PDE2 inhibitor 达特神经科学(开曼)有限公司 2019-08-06 CN claimed
CN-105007909-B Use of formyl peptide receptor 2 agonists for the treatment of ocular inflammatory diseases 阿勒根公司 2019-06-28 CN claimed
CN-109627248-A The method of level-one amine guiding building 6- (the bromo- 2- fluorophenyl of 4-) indoles simultaneously [1,2-a] quinoxaline 桂林理工大学 2019-04-16 CN claimed
CN-109336824-A The preparation of mek inhibitor and preparation comprising mek inhibitor 诺华股份有限公司 2019-02-15 CN claimed
CN-108884044-A PIPERIDINE DERIVATIVE 大塚制药株式会社 2018-11-23 CN claimed
CN-105176930-A Reprogramming cells SCRIPPS RESEARCH INST 2015-12-23 CN claimed
CN-105106199-A Methods of using MEK inhibitors EXELIXIS INC 2015-12-02 CN claimed
CN-103764144-A Synergistic combination of a PI3K inhibitor and a MEK inhibitor NOVARTIS AG 2014-04-30 CN claimed
CN-102532107-B 4-substituted aniline-7-substituted alcoxylhomopiperazine-quinazoline derivatives, and preparation method and application thereof TIANJIN INST PHARM RESEARCH 2014-03-12 CN claimed
CN-101679410-B 2-[(2-substituted)-ind0lizin-3-yl]-2-oxo-acetamide derivatives as antifungal agents F2G LTD 2013-11-27 CN claimed
CN-102421754-B Acrylamide derivative and use thereof in manufacture of medicament BEIJING SHIQIAO BIOPHAM CO LTD 2013-11-27 CN claimed
CN-103396409-A Pyrimidyl cyclopentanes as AKT protein kinase inhibitors ARRAY BIOPHARMA INC 2013-11-20 CN claimed
CN-101801955-B Pyrimidyl cyclopentanes as akt protein kinase inhibitors ARRAY BIOPHARMA INC 2013-05-08 CN claimed
EP-2421612-A1 HETEROCYCLIC COMPOUNDS AS MEK INHIBITORS Novartis AG (CH) 2012-02-29 EP claimed
EP-2344453-A2 ACTIVATORS OF HUMAN PYRUVATE KINASE The U.S.A. As Represented By The Secretary, Department Of Health And Human Services (US) 2011-07-20 EP claimed
WO-2010121646-A1 HETEROCYCLIC COMPOUNDS AS MEK INHIBITORS NOVARTIS AG (CH) 2010-10-28 WO claimed
WO-2010042867-A2 ACTIVATORS OF HUMAN PYRUVATE KINASE THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2010-04-15 WO claimed